Postmastectomy radiotherapy for breast cancer: Patterns, correlates, communication, and insights into the decision process

Cancer

Volumn 115, Issue 6, 2009, Pages 1185-1193

  Jagsi, Reshma ^a,b   Abrahamse, Paul ^b   Morrow, Monica ^c   Griggs, Jennifer J ^b   Schwartz, Kendra ^d   Katz, Steven J ^a,e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA Center for Clinical Management Research   (United States)

Author keywords

Breast neoplasms; Guideline adherence; Mastectomy; Quality of healthcare; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; COMORBIDITY; DEMOGRAPHY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SELF REPORT; TUMOR VOLUME; UNITED STATES;

ADULT; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COMMUNICATION; DECISION MAKING; FEMALE; HEALTH CARE SURVEYS; HUMANS; MASTECTOMY; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; TREATMENT REFUSAL;

EID: 63449132613     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24164     Document Type: Article

References (23)

1. McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg. 1986;73:264-266.
2. Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol. 1987;5:1546-1555.
3. Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol. 1998;16:2625-2631.
4. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355:1757-1770.
5. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949-955.
6. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641-1648.
7. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956-962.
8. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689-1700.
9. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol. 2000;18:2817-2827.
10. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from 5 National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2004;22:4247-4254.
11. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539-1569.
12. Ceilley E, Jagsi R, Goldberg S, et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys. 2005;61:365-373.
13. Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus statement on post- mastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:989-990.
14. Taylor ME, Haffty BG, Shank BM, et al. Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000;215(suppl):1153-1170.
15. Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference statement. J Natl Cancer Inst. 2001;93:979-989.
16. Punglia RS, Weeks JC, Neville BA, Earle CC. Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information. J Clin Oncol. 2006;24:3473-3482.
17. Smith BD, Haffty BG, Smith GL, et al. Use of postmastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys. 2008;71:98-106.
18. Punglia R, Hughes ME, Edge SB, et al. Factors associated with guideline-concordant use of radiotherapy after mastectomy in the National Comprehensive Cancer Network. Int J Radiat Oncol Biol Phys. 2008;72:1434-1440.
19. Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol. 2005;23:5526-5533.
20. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087-2106.
21. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with 4 or more positive nodes, as recommended by international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82:247-253.
22. Cheng SH, Horng CF, West M, et al. Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol. 2006;24:4594-4602.
23. Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J; Danish Breast Cancer Cooperative Group. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419-1426.